Healthcare: Biotech Buzz: ASCO Winners and Losers and Biogen's Discouraging Failure
Industry Focus
The Motley Fool
4.6 • 854 Ratings
🗓️ 8 June 2016
⏱️ 18 minutes
🧾️ Download transcript
Summary
What cancer drug companies came out ahead at this weekend's ASCO conference and a closer look at Biogen's recent disappointment.
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Welcome to Industry Focus, the podcast that dives into a different sector of the stock market every day. |
| 0:07.0 | It is Wednesday, June 8th, 2016, and we'll touch on |
| 0:13.0 | we're covering healthcare news from Asco, which was a huge cancer research |
| 0:14.3 | conference that happened last week and we'll touch on a big data release |
| 0:17.8 | from biogen that sent the stock down almost 13% yesterday. |
| 0:21.8 | I'm Christine Harjus and I've got Todd Campbell on the line. He is one of our |
| 0:25.4 | Motley Fool health care writers. What's going on Todd? |
| 0:28.0 | Hi Christine, I don't know if it's happening for you or for listeners but I feel like it's raining tree pollen right now. |
| 0:36.0 | Oh my gosh yesterday I was sharing an Uber with a girl who was just sneezing the entire ride down so I wasn't affected fortunately but I guess it's pretty bad here in |
| 0:44.9 | Alexandria as well. |
| 0:46.8 | Maybe we should do a show coming up on allergy drugs soon. |
| 0:50.4 | Sure, yeah, it's health care. |
| 0:51.7 | We're allowed to do that. We can talk about aller gin, that's |
| 0:54.7 | allergen, you know, it's basically the same, right? |
| 0:57.3 | There you go. |
| 0:59.3 | Anywho, so our first topic at the day, as I mentioned, is Asco, which was the American Society of Clinical Oncology. |
| 1:06.7 | They had their really important meeting where a lot of drug developers will present data and other interesting tidbits was held in Chicago. |
| 1:14.8 | So you highlighted for me a loser and a couple of winners when we were talking before the show. |
| 1:19.7 | Let's take the bad news first, that's generally my preference, so you called out immunometics as a loser. |
| 1:25.1 | Why? |
| 1:26.5 | This has got to be the strangest thing I've ever seen in years of following health care |
| 1:32.3 | out of Asco. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from The Motley Fool, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of The Motley Fool and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.